Study of Oglemilast for the Prevention of Asthma.

NCT00322283 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Exercise-Induced Asthma

Interventions

DRUG: Oglemilast
DRUG: Placebo

Sponsor

Forest Laboratories